Linamet ER Tablet is a fixed-dose combination of Linagliptin and Metformin Hydrochloride (Extended Release) used in the management of type 2 diabetes mellitus. It is prescribed for patients who require stronger glycemic control when diet, exercise, and single-agent therapy are not sufficient.

The extended-release formulation of Metformin ensures gradual drug release, improving tolerability and providing sustained blood glucose control throughout the day.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredients: Linagliptin + Metformin Hydrochloride (ER)
• Strength: 5 mg + 1000 mg
• Dosage Form: Extended-release oral tablet

Mechanism of Action

This combination works through dual complementary mechanisms:

Linagliptin:

• Inhibits the DPP-4 enzyme
• Increases incretin hormones (GLP-1 and GIP)
• Enhances glucose-dependent insulin secretion
• Reduces glucagon secretion from the liver

Metformin (ER):

• Decreases hepatic glucose production
• Improves peripheral insulin sensitivity
• Reduces intestinal glucose absorption
• Provides sustained release for better gastrointestinal tolerance and steady glucose control

Together, they help maintain consistent 24-hour glycemic regulation.

Indications

Linamet ER Tablet is indicated for:

• Type 2 diabetes mellitus
• Patients inadequately controlled on Metformin or other oral antidiabetic therapy
• Patients requiring combination therapy for improved glycemic control
• Adjunct to diet and exercise in adult patients with diabetes

Dosage and Administration

• Dosage is individualized based on blood glucose levels and clinical response
• Usually taken once daily with the evening meal
• Swallow whole; do not crush or chew (ER formulation)
• Regular blood glucose monitoring is recommended
• Dose adjustment may be required in renal impairment

Benefits

• Strong dual-action control of blood glucose
• Effective reduction of fasting and post-meal sugar levels
• Extended-release Metformin improves gastrointestinal tolerance
• Once-daily convenient dosing
• Low risk of hypoglycemia when used alone
• Supports long-term diabetes management

Side Effects

Common side effects may include:

• Nausea or vomiting
• Diarrhea (generally reduced with ER formulation)
• Abdominal discomfort
• Headache
• Nasopharyngitis

Less common but serious effects:

• Lactic acidosis (rare, associated with Metformin)
• Pancreatitis (rare, associated with Linagliptin)
• Hypoglycemia (mainly when combined with insulin or sulfonylureas)
• Allergic skin reactions

Precautions and Warnings

• Use only under medical supervision
• Regular monitoring of kidney function is required
• Avoid excessive alcohol consumption
• Temporarily discontinue before iodinated contrast imaging if advised
• Not indicated for type 1 diabetes or diabetic ketoacidosis
• Do not crush or chew extended-release tablets

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Use in Special Populations

• Pregnancy: Insulin is preferred; use only if prescribed
• Lactation: Consult physician before use
• Pediatrics: Not recommended
• Elderly: Requires careful dose adjustment and monitoring

Storage

• Store below 25°C
• Protect from moisture and light
• Keep in original packaging
• Keep out of reach of children.